REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201001:nBw5Ngpq5a
Form 8.3 - WILLIS TOWERS WATSON PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 30 September 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,304,967 1.79% 464,443 0.36%
(2) Derivatives (other than options):
355,000 0.28% 388,524 0.30%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
2,659,967 2.06% 852,967 0.66%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 10 209.5000 USD
Purchase 100 208.7800 USD
Purchase 100 209.2100 USD
Purchase 108 209.5700 USD
Purchase 165 208.9681 USD
Purchase 233 209.1399 USD
Purchase 300 209.2200 USD
Purchase 300 209.1766 USD
Purchase 300 209.1633 USD
Purchase 331 209.2177 USD
Purchase 350 209.3678 USD
Purchase 449 209.2657 USD
Purchase 573 209.4464 USD
Purchase 600 209.1966 USD
Purchase 666 209.2182 USD
Purchase 697 207.5400 USD
Purchase 700 209.2650 USD
Purchase 746 209.1477 USD
Purchase 1,630 209.1058 USD
Purchase 2,458 209.2798 USD
Purchase 4,767 208.8208 USD
Purchase 8,237 208.8200 USD
Purchase 10,894 209.0067 USD
Purchase 12,674 209.9399 USD
Purchase 13,430 210.5246 USD
Purchase 14,894 209.2298 USD
Purchase 17,437 208.8589 USD
Sale 4 209.8600 USD
Sale 35 209.3214 USD
Sale 100 210.9500 USD
Sale 100 211.0000 USD
Sale 108 209.5700 USD
Sale 124 209.2079 USD
Sale 143 211.3300 USD
Sale 197 207.5350 USD
Sale 200 207.5225 USD
Sale 233 210.9867 USD
Sale 300 207.5550 USD
Sale 301 210.4059 USD
Sale 375 211.0080 USD
Sale 435 211.0102 USD
Sale 466 211.0042 USD
Sale 475 210.9994 USD
Sale 670 211.0191 USD
Sale 745 210.0231 USD
Sale 795 210.8995 USD
Sale 800 209.2693 USD
Sale 933 210.9281 USD
Sale 1,910 210.7882 USD
Sale 1,911 209.5261 USD
Sale 2,980 209.2948 USD
Sale 3,511 210.9467 USD
Sale 5,307 209.6606 USD
Sale 5,988 210.0961 USD
Sale 10,866 208.8200 USD
Sale 13,136 209.0337 USD
Sale 17,437 208.8589 USD
Sale 20,000 209.2354 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 1 Oct 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201001005558/en/
(https://www.businesswire.com/news/home/20201001005558/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC - Transaction in Own Shares
AnnouncementREG - Barclays PLC Greencore Group PLC - Form 8.3 GREENCORE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
Announcement